Evidence map›Paper›PMID 32808850›Full record

ReviewSLAS technology2020

The Virological, Immunological, and Imaging Approaches for COVID-19 Diagnosis and Research.

An Sen Tan, Sanjna Nilesh Nerurkar, Wei Chang Colin Tan, Denise Goh, Chi Peng Timothy Lai, Joe Poh Sheng Yeong

Open access · bronzeAbstract readReview
In one paragraph

Review in SLAS technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. COVID-19 Diagnostics: A Panoramic View on Its Present Scenario, Challenges and Solutions.Proceedings of the National Academy of Sciences, India. Section B · 2022
    Review
  11. Review
  12. Performance of the T-SPOTInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

An Sen TanLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Sanjna Nilesh NerurkarYong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Wei Chang Colin TanYong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Denise GohInstitute of Molecular Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore.
Chi Peng Timothy LaiLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Joe Poh Sheng YeongInstitute of Molecular Cell Biology (IMCB), Agency of Science, Technology and Research (A*STAR), Singapore, Singapore.
Nanyang Technological University · SGNational University of Singapore · SGAgency for Science, Technology and Research · SGSingapore General Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2019, a novel coronavirus (SARS-CoV-2) was found to cause a highly contagious disease characterized by pneumonia. The disease (COVID-19) quickly spread around the globe, escalating to a global pandemic. In this review, we discuss the virological, immunological, and imaging approaches harnessed for COVID-19 diagnosis and research. COVID-19 shares many clinical characteristics with other respiratory illnesses.Accurate and early detection of the infection is pivotal to controlling the outbreak, as this enables case identification, isolation, and contact tracing. We summarize the available literature on current laboratory and point-of-care diagnostics, highlight their strengths and limitations, and describe the emerging diagnostic approaches on the horizon.We also discuss the various research techniques that are being used to evaluate host immunity in laboratory-confirmed patients. Additionally, pathological imaging of tissue samples from affected patients has a critical role in guiding investigations on this disease. Conventional techniques, such as immunohistochemistry and immunofluorescence, have been frequently used to characterize the immune microenvironment in COVID-19. We also outline the emerging imaging techniques, such as the RNAscope, which might also aid in our understanding of the significance of COVID-19-specific biomarkers, such as the angiotensin-converting enzyme 2 (ACE2) cellular receptor.Overall, great progress has been made in COVID-19 research in a short period. Extensive, global collation of our current knowledge of SARS-CoV-2 will provide insights into novel treatment modalities, such as monoclonal antibodies, and support the development of a SARS-CoV-2 vaccine.

Indexed as

Angiotensin-Converting Enzyme 2Antigens, ViralBiomarkersCOVID-19COVID-19 VaccinesDiagnostic ImagingHumansPoint-of-Care TestingSARS-CoV-2T-LymphocytesAngiotensin-Converting Enzyme 2Antigens, ViralBiomarkersCOVID-19 VaccinesCOVID-19diagnosticsimmunologypathologyspecific T cells

Identifiers

PMID32808850
PMCPMC7435207
OpenAlexW3049187445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.